University Hospital Zurich, Research and Education Office
https://www.usz.ch/forschung/Seiten/default.aspx
8091 Zürich, Rämistrasse 100
The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.
University Hospital Zurich, Research and Education Office
Rämistrasse 100
8091 Zürich
316 Ergebnisse für "therapeutischen com com" unter University Hospital Zurich, Research and Education Office
... Colchizin evaluiert werden. Da sich in den letzten Jahren die therapeutischen Op- tionen für Patienten mit ... nicht-kovalent gebun- dene leichte Kette der Klasse-I-Major Histocompatibility Com plex- (MHC-)Moleküle ... Colchizin evaluiert werden. Da sich in den letzten Jahren die therapeutischen Op- tionen für Patienten mit ... nicht-kovalent gebun- dene leichte Kette der Klasse-I-Major Histocompatibility Com plex- (MHC-)Moleküle ...
University of Zurich
https://www.campus-schlieren.uzh.ch/en.html
8952 Schlieren, Wagistrasse 12
The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.
University of Zurich
Wagistrasse 12
8952 Schlieren
838 Ergebnisse für "therapeutischen com com" unter University of Zurich
UZH - UFSP Dynamik Gesunden Alterns - Dipl. rer. com. Susanne Nieke
... Susanne Nieke, Dipl. rer. com. Wissenschaftliche Mitarbeiterin ... UZH - UFSP Dynamik Gesunden Alterns - Dipl. rer. com. Susanne Nieke ... UZH - UFSP Dynamik Gesunden Alterns - Dipl. rer. com. Susanne Nieke Home Hauptnavigation Suche ... UZH - UFSP Dynamik Gesunden Alterns - Dipl. rer. com. Susanne Nieke ...
UZH - URPP Dynamics of Healthy Aging - Dipl. rer. com. Susanne Nieke
... Susanne Nieke, Dipl. rer. com. Wissenschaftliche Mitarbeiterin ... UZH - URPP Dynamics of Healthy Aging - Dipl. rer. com. Susanne Nieke ... UZH - URPP Dynamics of Healthy Aging - Dipl. rer. com. Susanne Nieke Home Main navigation Search ... UZH - URPP Dynamics of Healthy Aging - Dipl. rer. com. Susanne Nieke ...
ETH Entrepreneurship
https://ethz.ch/en/industry/entrepreneurship.html
8952 Schlieren, Wagistrasse 18
Excellence in entrepreneurship at ETH Zurich is driven by world-class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions.
ETH Entrepreneurship
Wagistrasse 18
8952 Schlieren
1507 Ergebnisse für "therapeutischen com com" unter ETH Entrepreneurship
Consequences of pseudo-participatory approaches towards post-disast...
... com ... com ...
Consequences of pseudo-participatory approaches towards post-disast...
... com ... com ...
Somagenetix
https://www.wysszurich.ch/projects/somagenetix
8952 Schlieren, Wagistrasse 23
Gene therapy solutions for patients with severe inherited diseases.
Somagenetix
Wagistrasse 23
8952 Schlieren
709 Ergebnisse für "therapeutischen com com" unter Somagenetix
Entrevista com João Adolfo Hansen por Eduardo Jorge de Oliveira, Jú...
... Entrevista com João Adolfo Hansen por Eduardo Jorge de Oliveira, Júlia de Carvalho Hansen e Marcela ... professor que, através do turno da noite lidou com a realidade brasileira de textos, dentre outros, os de ... Entrevista com João Adolfo Hansen por Eduardo Jorge de Oliveira, Júlia de Carvalho Hansen e Marcela ... Entrevista com João Adolfo Hansen por Eduardo Jorge de Oliveira, Júlia de Carvalho Hansen e Marcela ... Entrevista com João Adolfo Hansen por Eduardo Jorge de Oliveira, Júlia de Carvalho Hansen e Marcela ...
Entrevista com Raúl Antelo por Eduardo Jorge de Oliveira, Eduardo S...
... de Oliveira, Eduardo Jorge ; Sterzi, Eduardo ; Stigger, Verônica (2020). Entrevista com Raúl Antelo ... seminário Museus e materialidades da literatura. Com trânsito livre entre Brasil e Argentina, ou melhor, com ... Entrevista com Raúl Antelo por Eduardo Jorge de Oliveira, Eduardo Sterzi e Verônica Stigger ... Entrevista com Raúl Antelo por Eduardo Jorge de Oliveira, Eduardo Sterzi e Verônica Stigger ... Entrevista com Raúl Antelo por Eduardo Jorge de Oliveira, Eduardo Sterzi e Verônica Stigger ...
CUTISS AG
8952 Schlieren, Grabenstrasse 11
+41 44 244 36 60
info@cutiss.swiss
After more than 15 years of research (Tissue Biology Research Unit, University Children’s Hospital Zurich), CUTISS AG can now bio-engineer large quantities of individually customized human skin grafts, denovoSkin™, starting off from a very small piece of healthy patient’s skin. Because of its intrinsic characteristics, denovoSkin™ is expected to result in a minimally scarring outcome after transplantation. denovoSkin™ received a Swissmedic, EMA and FDA Orphan drug designation for the treatment of burns.
CUTISS AG
Grabenstrasse 11
8952 Schlieren
6 Ergebnisse für "therapeutischen com com" unter CUTISS AG
Fallstudie: denovoSkin™ in der rekonstruktiven pädiatrischen Verbre...
... Com ... Com ...
Standortförderung Kanton Zürich
https://www.zh.ch/de/volkswirtschaftsdirektion/amt-fuer-wirtschaft/standortfoerderung.html
8090 Zürich, Walchestrasse 19
+41 43 259 49 92
standort@vd.zh.ch
The Division of Business and Economic Development supports resident companies, promotes Zurich's innovation capacity by way of connecting the relevant stakeholders in key industries, fosters external economic relations and offers guidance to companies interested in moving to Zurich.
Standortförderung Kanton Zürich
Walchestrasse 19
8090 Zürich
115 Ergebnisse für "therapeutischen com com" unter Standortförderung Kanton Zürich
... , ihr nach Austritt aus der therapeutischen Gemeinschaft einen Bericht über den Therapieverlauf und ... , ihr nach Austritt aus der therapeutischen Gemeinschaft einen Bericht über den Therapieverlauf und ...
... Portugiesisch Conversas com os pais e certificado. Jardim de infân- cia e 1./2. ano do ensino básico (1.ciclo ... crianças aprendem cada vez mais com a ajuda de tarefas específicas e práticas. Num ensino de sucesso ... Portugiesisch Conversas com os pais e certificado. Jardim de infân- cia e 1./2. ano do ensino básico (1.ciclo ... crianças aprendem cada vez mais com a ajuda de tarefas específicas e práticas. Num ensino de sucesso ...
Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
133 Ergebnisse für "therapeutischen com com" unter Roche Glycart AG
Investidores - Código de Conduta do Grupo Roche
... Investidores Dialogamos com os investidores de modo transparente Os investidores querem que a Roche ... sociedade. A Roche está comprometida a dialogar e interagir com os investidores de modo transparente ... Dialogamos com os investidores de modo transparente Os investidores querem que a Roche gere um retorno ... está comprometida a dialogar e interagir com os investidores de modo transparente, constante e ...
Informações confidenciais - Código de Conduta do Grupo Roche
... Informações confidenciais Lidamos de forma cuidadosa com informações confidenciais, para proteger ... compartilhar informações confidenciais com ninguém que não seja empregado da Roche, nem mesmo com outros ... confidenciais Lidamos de forma cuidadosa com informações confidenciais, para proteger os bens e os interesses da ... informações confidenciais com ninguém que não seja empregado da Roche, nem mesmo com outros empregados que não ...
OMNIMEDICA Group AG
8952 Schlieren, Lättenstrasse 27
The company develops and distributes active ingredients and end products in the field of cosmeceuticals, nutritional supplements, sports, palliative medicine, dental medicine and detoxification/filter systems.
OMNIMEDICA Group AG
Lättenstrasse 27
8952 Schlieren
5 Ergebnisse für "therapeutischen com com" unter OMNIMEDICA Group AG
Omnimedica Care System Archive | OMNIMEDICA
... Omnimedica Care System – Anti-Aging und Zellschutz der klinisch- therapeutischen Kosmetikprodukte ... - therapeutischen Kosmetikprodukte durch Aktivstoff OM24® – Swiss Made Ergebnisse 1 – 9 von 18 werden angezeigt Nach ...
Anti Aging Archive | Omnimedica Group AG
... Schutz in klinisch- therapeutischen Kosmetikprodukten – Swiss Made. Zeigt alle 9 Ergebnisse ... , junge und frische Haut. Der weltbeste Anti-Aging Schutz in klinisch- therapeutischen Kosmetikprodukten ...
InSphero AG
8952 Schlieren, Wagistrasse 27
+41 44 515049-0
info@insphero.com
InSphero is a leading supplier of organotypic, biological in vitro 3D microtissues for highly predictive drug testing. The company currently counts all of the top ten global pharmaceutical and cosmetics companies as customers and is helping them to implement its patented microtissue technology in their development work-flow.
InSphero AG
Wagistrasse 27
8952 Schlieren
4 Ergebnisse für "therapeutischen com com" unter InSphero AG
... > View latest Newsletters 04/2014 - ... href="http://us2.campaign-archive1. com/?u=12bba0b8698d7ada929228dd1&id=c6a20676cb&e=88dc08ae62 ... > View latest Newsletters 04/2014 - ... href="http://us2.campaign-archive1. com/?u=12bba0b8698d7ada929228dd1&id=c6a20676cb&e=88dc08ae62 ...
Newsletter Archive
... > View latest Newsletters 04/2014 - ... href="http://us2.campaign-archive1. com/?u=12bba0b8698d7ada929228dd1&id=c6a20676cb&e=88dc08ae62 ... > View latest Newsletters 04/2014 - ... href="http://us2.campaign-archive1. com/?u=12bba0b8698d7ada929228dd1&id=c6a20676cb&e=88dc08ae62 ...
Evax AG
8952 Schlieren, Wagistrasse 21
We are a spin-off company of the University of Zurich, transferring human standards of care into horses. Our research team develops therapeutical vaccines to treat chronic diseases, allergies and respiratory diseases. Our vision is to address diseases in horses with modern research to contribute to the growing knowledge in the pharmaceutical industry.
Evax AG
Wagistrasse 21
8952 Schlieren
6 Ergebnisse für "therapeutischen com com" unter Evax AG
Neue Zusammenarbeit von Evax mit AGC Biologics - EVAX
... Wir arbeiten mit AGC Biologics zusammen für die Entwicklung und Produktion von therapeutischen ... mit AGC Biologics zusammen für die Entwicklung und Produktion von therapeutischen Impfstoffen zur ...
Investoren - EVAX
... Kommerzialisierung unseres führenden therapeutischen Impfstoffkandidaten, der in die GMP-Produktion und ... unseres führenden therapeutischen Impfstoffkandidaten, der in die GMP-Produktion und Zulassungsstudien ...